Owlet

Lehi, UT, USA Healthcare Public

Owlet is a connected infant health monitoring company that develops FDA-cleared wearable pulse oximetry devices for infants. The company's flagship products are the Dream Sock, an over-the-counter medical-grade pulse oximeter for infants 1-18 months, and BabySat, which provide real-time monitoring of oxygen saturation and heart rate. Owlet went public via SPAC merger with Sandbridge Acquisition Corporation in July 2021 (NYSE: OWLT) and has since pivoted to FDA-cleared medical devices after previous regulatory challenges with its original Smart Sock product.

Public Company

Owlet is publicly traded

This company is no longer available on our private secondary market. Shares can be traded publicly under its listed ticker.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

2013

Employees

250–350

Total Funding

$402.85M

6 rounds

Latest Valuation

$1.07B

February 2023

Funding

Total raised $402.85M across 6 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 06-25-2026

Latest Round

Type

SPAC merger (IPO)

Date

July 16, 2021

Amount

$325M

Valuation

$1.07B

Lead Investors

Sandbridge Acquisition Corporation + PIPE
DateRoundAmount RaisedValuationLead Investors
February 2023 Convertible preferred (post-IPO) $30M Eclipse Ventures, Trilogy Equity Partners
July 16, 2021 SPAC merger (IPO) $325M $1.07B Sandbridge Acquisition Corporation + PIPE
May 2018 Series B $24M Trilogy Equity Partners

Leadership

  • Kurt Workman

    President and Chief Executive Officer

    LinkedIn

Competitors

Competitor list is illustrative and may be incomplete, stale, or erroneous.

  • Nanit

    Founded 2014; WiFi-enabled baby monitor with sleep tracking, temperature/humidity monitoring, and breathing motion monitoring via unique fabric pattern (no sensors/radar required)

  • Sense-U

    Clip-on wearable device that attaches to diaper/clothing; tracks breathing movements, sleep position, and ambient temperature around baby

  • Eufy

    Smart baby monitor with video and audio capabilities; competes in the consumer WiFi-enabled monitor segment

  • Miku

    Smart baby monitor offering WiFi-enabled video, audio, and sensor-free breathing monitoring

  • Babysense

    Infant breathing monitor offering under-the-mattress sensor technology for sleep and breathing tracking

Owlet Investment FAQ

Owlet FAQ

Owlet completed its SPAC merger with Sandbridge Acquisition Corporation on July 15, 2021, and began trading on NYSE under ticker OWLT. The company achieved significant validation in 2023 with FDA De Novo clearance for its Dream Sock product as a Class II medical device—the first and only over-the-counter medical-grade pulse oximeter cleared for infants. 2024 was a strong year with 45% revenue growth ($78.1M) and narrowed losses, driven by Dream Sock adoption across multiple distribution channels. Company reaffirmed guidance post-CEO transition in April 2026 when founder Kurt Workman returned as CEO.

Owlet shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker to place an order.

Owlet had a valuation of approximately $1.07B at the time of its public offering. Current market capitalization fluctuates with the share price.

Owlet raised $402.85M across 6 disclosed funding rounds prior to its public listing.

Owlet is headquartered in Lehi, UT, USA.

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.